COMMENTARY ON 'PERSPECTIVES ON THE CLINICAL USE OF PHARMACOGENETIC TESTING IN LATE-LIFE MENTAL HEALTHCARE: A SURVEY OF THE AMERICAN ASSOCIATION OF GERIATRIC PSYCHIATRY MEMBERSHIP'

Author(s):  
Parnika Prashasti Saxena
2010 ◽  
Vol 22 (8) ◽  
pp. 1193-1195 ◽  
Author(s):  
Mark Rapoport ◽  
Benoit H. Mulsant

In September 2009, Montreal, Quebec hosted the International Psychogeriatric Association's 14th International Congress, in collaboration with the American Association for Geriatric Psychiatry, the Canadian Academy of Geriatric Psychiatry, the Canadian Coalition for Seniors' Mental Health, the Canadian Geriatrics Society, and the Société Québecoise de Psychogériatrie. The theme of the Congress was the “Pathway to Prevention”, and the presentations focused on progress made to date on the prevention of late-life mental disorders, barriers the field is still facing, and future achievements that will be needed for this goal to be achieved.


2015 ◽  
Vol 27 (10) ◽  
pp. 1749-1750 ◽  
Author(s):  
Delphine Raucher-Chéné ◽  
Nicolas Hoertel ◽  
Céline Béra-Potelle ◽  
Sarah Terrien ◽  
Sarah Barrière ◽  
...  

The increased life expectancy in people with severe and persistent psychiatric illness, such as schizophrenia or bipolar disorder, has been predicted to substantially affect mental healthcare system (Bartels et al., 2002) that must adapt to meet the needs of older adults (Jeste et al., 1999). Development of specialized geriatric psychiatry services is thus needed.


Sign in / Sign up

Export Citation Format

Share Document